Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5G23D | IM / RA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Z006282 | SC / LL |
About 10 minutes after vaccine administration patient developed a nonpruritic rash on her face only. The rash was mildly erythematous and raised. There was no difficulty breathing, throat swelling or pain, pruritus. Patient was evaluated immediately after and provided Benadryl. Patient was walking and talking at baseline. A prescription was sent for Benadryl and prednisone if symptoms worsen. Patient's parent was given strict ED precautions.
None
None
None
None